Thioridazine HCl 25 mg Oral Tablet
RxNorm 198274
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 198274 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: thioridazine HCl 25 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Thioridazine 25 mg Oral Tablet
(Atom ID: 12324390)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely thioridazine hydrochloride 25 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10317755)
SYPrescribable
Synonym (SY):
Thioridazine (as thioridazine hydrochloride) 25 mg Oral Tablet
(Atom ID: 3642698)
PSNPrescribable
Prescribable Name (PSN):
Thioridazine HCl 25 mg Oral Tablet
(Atom ID: 7739547)
PTPrescribable
Designated preferred name (PT):
Thioridazine hydrochloride 25 mg oral tablet
(Atom ID: 9265062)
Patient Education
Thioridazine
Thioridazine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in people who have already been treated with at least 2 other medications and have not been helped or who have experienced severe side effects. Thioridazine is in a group of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
[Learn More]
* Please review the disclaimer below.